Cargando…
Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
BACKGROUND: Over 40 years of use demonstrates that complement 1 esterase inhibitor (C1-INH) concentrate is effective and well tolerated for acute edema attacks and prophylaxis in patients with hereditary angioedema. OCTA-C1-INH is a new stable, virus-inactivated, nanofiltrated concentrate of C1-INH...
Autores principales: | Martinez-Saguer, Inmaculada, Bork, Konrad, Latysheva, Tatiana, Zabrodska, Liudmyla, Chopyak, Valentyna, Nenasheva, Natalia, Totolyan, Areg, Krivenchuk, Vitaliy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684372/ https://www.ncbi.nlm.nih.gov/pubmed/38033485 http://dx.doi.org/10.1016/j.jacig.2023.100178 |
Ejemplares similares
-
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014) -
WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012) -
On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
por: Aygören-Pürsün, Emel, et al.
Publicado: (2010) -
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
por: Bork, Konrad
Publicado: (2010) -
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
por: Agostoni, Angelo, et al.
Publicado: (2004)